If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,500.00
Bid: 4,460.00
Ask: 4,500.00
Change: 0.00 (0.00%)
Spread: 40.00 (0.897%)
Open: 4,500.00
High: 4,500.00
Low: 4,500.00
Prev. Close: 4,480.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to UK media reports on Kakuzi Plc

12 Oct 2020 07:00

RNS Number : 7114B
Camellia PLC
12 October 2020
 

12 October 2020

 

Camellia Plc (the "Company")

Response to UK media reports on Kakuzi Plc

 

An article published on 11 October 2020 by UK newspaper the Sunday Times highlighted that Camellia Plc (the "Company") is facing legal claims relating to allegations against employees of one of its investee companies in Kenya: Kakuzi Plc. These claims have been brought on a no-win no-fee basis by UK law firm Leigh Day in the UK. Leigh Day is not licensed to practice law in Kenya.

 

Camellia purchased a 50.7% stake in Kakuzi Plc in the mid-1990s. Kakuzi is a Kenyan agricultural company employing around 3,000 Kenyans and has been trading on the Nairobi Securities Exchange for over 50 years. It is managed by its own board of directors on behalf of its 1,300 shareholders, most of whom are Kenyan.

 

Further to the update provided on 8 October 2020, and in other announcements to the market this year, Camellia wishes to reiterate that it takes these complaints against its foreign operations extremely seriously. The welfare of people working across the Group and their communities is of vital importance. This is reflected in the Company's values, culture, and by the examples presented in its ESG report: Custodianship which can be found on Camellia's website.

 

Camellia understands that the allegations are being investigated by Kakuzi to ensure wrongdoing can be addressed and internal safeguarding procedures improved, if necessary. However, Kakuzi has also advised its shareholders, including Camellia, in a statement issued on 11 October 2020, that it has a number of concerns with the Sunday Times' article and Leigh Day's approach to these claims. Kakuzi notes the following:

 

1. Leigh Day's insistence on anonymity for those making these claims hinders the investigation to get justice for those who seek it, or to resolve the claims quickly. As far as Kakuzi is aware, few of the allegations have ever been reported to Kakuzi or the Kenyan authorities.

2. In July 2020 Leigh Day dropped its UK Court claims against Kakuzi. Kakuzi believes that Leigh Day is running a smear campaign against Kakuzi and some of its customers.

3. It is unfathomable that a UK law firm regards Kenya's legal system as incapable of dealing with alleged criminal acts by Kakuzi employees against other Kenyans.

4. Kakuzi asked the Kenyan Director of Public Prosecutions to investigate the allegations from Leigh Day and to take appropriate steps under Kenyan law.

5. Kakuzi has fully funded independent legal advice and professional counselling services available for any claimant as part of an Alternative Dispute Resolution (ADR) process recognised under the Kenyan Constitution. Anonymity is provided within this system.

 

Camellia is aware that Kakuzi undertakes regular third party local and international accreditation audits for the governance of its sector. These are made available to Kakuzi's trade partners, including the Ethical Trading Initiative (ETI) and customers. Camellia understands that Kakuzi has also updated an agreed Action Plan following an ETI assessment in 2019 and Kakuzi would welcome a fresh independent audit.

 

While Kakuzi rightly continues to investigate these grave allegations, Camellia - as a responsible shareholder - fully expects Kakuzi and its board to ensure that all allegations are urgently and exhaustively examined, that justice is served if wrongdoing is uncovered, and that key stakeholders including customers are regularly updated on their progress.

 

Camellia is of course, as far as possible, investigating matters in the context of the claims it is facing, and will continue to update its own shareholders.

 

 

 

Enquiries

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPFFFVLIVLLLII
Date   Source Headline
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc
8th Oct 20205:15 pmRNSUpdate on African allegations
7th Oct 202011:00 amRNSDirector/PDMR Shareholding
25th Sep 20209:58 amRNSInterim Report 2020
25th Sep 20207:00 amRNSHalf-year Report
15th Sep 202010:53 amRNSNotice of Interim Results
17th Aug 20201:55 pmRNSAsset Disposal Amendment
17th Aug 202011:17 amRNSAsset Disposal
10th Jun 20201:03 pmRNSCorrection to Result of AGM
10th Jun 202012:24 pmRNSResult of AGM
10th Jun 202011:30 amRNSAGM Trading Statement
15th May 202011:00 amRNSAnnual Report and Notice of Annual General Meeting
7th May 20203:18 pmRNSFinal Results
27th Apr 20207:00 amRNSTrading update
1st Apr 202012:00 pmRNSTrading update
26th Mar 20204:37 pmRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSDirectorate Changes
21st Jan 20207:00 amRNSTrading Update
15th Aug 201910:51 amRNSInterim Report 2019
15th Aug 20197:00 amRNSHalf-year Report
7th Jun 201911:00 amRNSResult of AGM
6th Jun 201911:30 amRNSAGM Trading Statement
15th Apr 201912:13 pmRNSAnnual Report and Notice of AGM
11th Apr 20197:00 amRNSFinal Results
21st Mar 20194:40 pmRNSSecond Price Monitoring Extn
21st Mar 20194:35 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSTrading update
23rd Oct 20187:00 amRNSTrading Update
29th Aug 201811:40 amRNSInterim Report 2018
24th Aug 20187:00 amRNSHalf-year Report
8th Jun 201812:20 pmRNSResult of AGM
7th Jun 201811:30 amRNSAGM Trading Statement
25th Apr 20184:00 pmRNSAnnual Report and Notice of AGM
20th Apr 20181:57 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSFinal Results
21st Mar 20187:00 amRNSNotice of Results
22nd Dec 20179:42 amRNSDirectorate Change
6th Dec 201712:28 pmRNSTrading Statement
14th Nov 20173:00 pmRNSHolding(s) in Company
29th Aug 20173:20 pmRNSInterim report 2017
25th Aug 20177:00 amRNSHalf-year Report
2nd Jun 20171:13 pmRNSResult of AGM
1st Jun 201711:30 amRNSAGM Statement
11th May 20177:00 amRNSUpdate on Duncan Lawrie
2nd May 20172:05 pmRNSAnnual Financial Report
27th Apr 20177:00 amRNSFinal Results
21st Apr 20175:03 pmRNSUpdate on Duncan Lawrie
19th Dec 20167:00 amRNSUpdate on Duncan Lawrie
22nd Nov 20165:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.